This is another in the excellent Seminar series in the Lancet. The Seminars are based on extensive literature searches and the search criteria used to interrogate the PubMed and EMBASE databases are included. The period searched was 2000--05 so all the information is bang up to date and the recent advances in science and clinical medicine have helped rewrite some of the popular assumptions about this disorder.
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Nearly 80--85% of phaeochromocytomas 'arise from the adrenal medulla', and whereas the sporadic tumours are typically diagnosed in the fourth to ¢fth decade of life, the hereditary forms are mostly diagnosed before the age of 40. Phaeochromocytoma is often referred to as the great mimic, as it shares signs and symptoms with many other conditions tabulated in the article.
Because of increasing use of advanced imaging techniques and improved recognition of genetic causes, the numbers of normotensive patients and patients with adrenal incidentalomas has risen steadily. Some interesting ¢gures gleaned from imaging studies include 25% of all phaeochromocytomas being discovered incidentally during imaging studies; and conversely --5% of all incidentalomas are phaeochromocytomas. Despite improvements in diagnostics there is usually a delay of three years between initial symptoms and a ¢nal diagnosis because of the non-speci¢city of the individual symptoms. However, taken together as a triad, the headaches, palpitations and sweating are virtually pathognomonic for the condition. Advances in genetics also challenge the 10% rule --and there is overwhelming evidence that the ¢gure of 10% for the hereditary basis has raised to 24% for familial phaeochromocytomas. Germline mutations in ¢ve genes have been identi¢ed in association with familial phaeochromocytomas. New mutations for me are those in the genes encoding the B and D subunits of mitochondrial succinate dehydrogenase, which have been identi¢ed in about 3--11% of patients with non-syndromic phaeochromocytomas. The chroma⁄n tumours associated with these tumours produce predominantly noradrenaline. There is a suggestion that all patients presenting with a phaeochromocytoma be submitted to genetic testing, and that this can be directed to speci¢c mutation testing based on the biochemistry (bilateral adrenaline secreting tumours or phaeochromocytomas associated with medullary thyroid carcinoma indicated the need for screening for mutations in the RET gene). Genetic testing very much complements the initial biochemical or imaging-based diagnostics. Biochemical screening for phaeochromocytoma is not advocated for asymptomatic patients with hypertension. The most recent test to appear is free metadrenalines in plasma and this would now appear to be the most sensitive and speci¢c screening test, in association with the urine-based assay, with respective sensitivities of 99% and 97%. However, there is the issue of speci¢city, no matter how good the test, with the number of false positives exceeding true positives because the patients tested have increased sympathetic activity and circulating catecholamines. There is a nice table indicating the likelihood of a phaeochromocytoma at di¡erent numerical cut-o¡s for the tests used. Drugs, dietary interferences and inappropriate sampling conditions are causes of moderately elevated results and the various interfering substances are listed. Imaging should only be initiated when there is unequivocal biochemical evidence of a phaeochromocytoma. Computerized tomography and magnetic resonance imaging can be followed up with MIBG functional imaging but be aware of the e¡ects of prolonged radioactivity for the unsuspecting traveller caught in radiation detectors --see Piscator ibid. In conclusion, this is an excellent up-to-date review of the literature highlighting the increased incidence of hereditary phaeochromocytomas and the role of biochemistry and imaging in the diagnostic process.
King George III and porphyria; an elemental hypothesis and investigation Cox TM, Jack N, Lofthouse S, Watling J, Haines J, Warren MJ Lancet 2005;366:332-5
As someone close to being consigned to medical history herself --diagnosis as yet unknown --this article in the Department of Medical History series probing the madness of King George makes compelling reading, irrespective of whether or not you have seen the eponymous ¢lm.
It appeared in the dog days of summer, but I expect those who read the journal for pleasure rather than CPD may well have been found with the open edition £at against their heaving chest as they lay dozing in the summer sunshine --a porphyria-inducing (for those with the sensitivity) alcoholic beverage to hand. Rumours started circulating in the late 1960s that the House of Hanover and King George III in particular were a¥icted by a porphyric illness --variegate porphyria (VP), or por¡yria if you are Welsh. A mother and son team of British psychiatrists reviewed the clinical records and did a thorough examination of the family tree and a de¢nitive diagnosis of VP was actually made in a Hanoverian descendant in 1968. The doughty detectives from the venerable Ivy League institutions from around the globe speculated that exposure to environmental factors and heavy metals in particular could have been the precipitant for the regal attacks. Heavy metals are potent inhibitors of enzymes of the haem biosynthetic pathway. Apart from a lock of hair removed from the regal pate on the ultimate bad hair day, there is no other preserved biological material which could allow this diagnosis to be pursued. They now have evidence that arsenic could be implicated. Attempts to extract DNA from the preserved hair were unsuccessful, but after washing the hair and subjecting it to acid digest, the metal content was determined by inductively coupled plasma mass spectrometry. The control data was from adult volunteers, which does not exactly mimic a preserved sample from nearly two centuries ago. There was an unexpectedly signi¢cant increase in the arsenic content and the detail of the extraction and the segmental analysis would support the arsenic being incorporated into the hair shaft rather than a coating on it. The deposition of arsenic was evenly distributed along the hair shaft, suggesting that is was incorporated during life. Arsenic interferes with several enzymes of the haem biosynthetic pathway and although there is no direct evidence that arsenic alone produces porphyric attacks, exposure to it contained in 'moonshine' liquor does precipitate VP. If George III did indeed inherit VP, he would be sensitised to poisoning at concentrations much lower than those without the defect. The probable source of the arsenic is contamination of the antimony-based medication --the emetic tartar, which was potassium antimony tartrate. A rarity amongst the good folk acknowledged in the preparation of the article is our current Royal Highness.
